TP53 and glioma: Tables 1 and 2 reveal that remote recurrences of IDH and TP53 mutant gliomas result in poor prognoses; therefore, we hypothesized that an 8q gain may be a poor prognostic factor in IDH and TP53 mutant gliomas.